Tenax Therapeutics (TENX) Return on Capital Employed (QoQ) (2011 - 2026)

Tenax Therapeutics (TENX) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Tenax Therapeutics 655.78 Mn 655.78 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.00
Dec 31, 2025 -1,019.00
Sep 30, 2025 -1,540.00
Jun 30, 2025 -643.00
Mar 31, 2025 -566.00
Dec 31, 2024 2,727.00
Sep 30, 2024 12,405.00
Jun 30, 2024 -4,825.00
Mar 31, 2024 1,405.00
Dec 31, 2023 -17,329.00
Sep 30, 2023 -203.00
Jun 30, 2023 -4,397.00
Mar 31, 2023 -41,562.00
Dec 31, 2022 141,453.00
Sep 30, 2022 23,140.00
Jun 30, 2022 71,214.00
Mar 31, 2022 -130,527.00
Dec 31, 2021 -128,494.00
Sep 30, 2021 -47,869.00
Jun 30, 2021 48,474.00